Abstract
Allyl isothiocyanates (AITC) have gained recognition in recent years as effective chemotherapeutic and epigenetic modulators. The chemopreventive properties and toxicological perspectives of AITCs from the last few decades were taken into account by a number of investigations. Their active therapeutic relevance was hindered by a number of factors, including instability under typical physiological conditions and low bioavailability due to low aqueous solubility. In this review, we highlighted the chemopreventive attributes of AITC in relation to its molecular mechanisms and metabolic fate for cancer. Moreover, we emphasized on investigational anticancer activities and various strategies for delivery of AITC in different types of cancer. Considering cellular interactions, we shed light on the toxicological properties of AITCs to address further issues regarding their assessment in therapeutic development. This review identifies knowledge gaps with various contemporary approaches involving most recent studies and may pave the way for a better understanding for the development of novel AITC therapeutics.
Graphical abstract
Similar content being viewed by others
Data availability
All data available in a submitted manuscript.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71:209–249
Koehn FE (2012) Natural products and cancer drug discovery. Springer Science & Business Media
Hu Y, Chen J, Hu G, Yu J, Zhu X, Lin Y, Chen S, Yuan J (2015) Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012. Mar Drugs 13:202–221. https://doi.org/10.3390/md13010202
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66:1022–1037
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharma Bull 7:339. https://doi.org/10.15171/apb.2017.041
Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21:3233. https://doi.org/10.3390/ijms21093233
Cuellar-Nuñez ML, Luzardo-Ocampo I, Lee-Martínez S, Larrauri-Rodríguez M, Zaldívar-Lelo de Larrea G, Pérez-Serrano RM, Camacho-Calderón N (2022) Isothiocyanate-rich extracts from cauliflower (Brassica oleracea Var Botrytis) and radish (Raphanus sativus) inhibited metabolic activity and induced ROS in selected human HCT116 and HT-29 colorectal cancer cells. Int J Environ Res Public Health 19:14919
Charron CS, Clevidence BA, Albaugh GA, Kramer MH, Vinyard BT, Milner JA, Novotny JA (2013) Assessment of DNA damage and repair in adults consuming allyl isothiocyanate or Brassica vegetables. J Nutr Biochem 24:894–902
Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA (1996) Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Prev Biomarkers 5:733–748
Wu X, Huang H, Childs H, Wu Y, Yu L, Pehrsson PR (2021) Glucosinolates in Brassica vegetables: characterization and factors that influence distribution, content, and intake. Annu Rev Food Sci Technol 12:485–511
Mithen RF, Dekker M, Verkerk R, Rabot S, Johnson IT (2000) The nutritional significance, biosynthesis and bioavailability of glucosinolates in human foods. J Sci Food Agric 80:967–984
Cheung KL, Kong A-N (2010) Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12:87–97. https://doi.org/10.1208/s12248-009-9162-8
Jakubikova J, Bao Y, Sedlak J (2005) Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res 25:3375–3386
Fimognari C, Lenzi M, Hrelia P (2009) Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells. Environ Mol Mutagen 50:171–189
Ioannides C, Konsue N (2015) A principal mechanism for the cancer chemopreventive activity of phenethyl isothiocyanate is modulation of carcinogen metabolism. Drug Metab Rev 47:356–373
Chiang JH, Tsai FJ, Hsu YM, Yin MC, Chiu HY, Yang JS (2020) Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells. Oncol Rep 44:1415–1424
Chang P-y, Tsai F-j, Bau D-t, Hsu Y-m, Yang J-s, M-g Tu, Chiang S-l (2021) Potential effects of allyl isothiocyanate on inhibiting cellular proliferation and inducing apoptotic pathway in human cisplatin-resistant oral cancer cells. J Formos Med Assoc 120:515–523
Liao C-L, Peng S-F, Chen J-C, Chen P-Y, Huang A-C, Lien J-C, Chueh F-S, Chiang T-A, Wu P-P, Lin K-I (2021) Allyl isothiocyanate induces DNA damage and impairs DNA repair in human breast cancer MCF-7 cells. Anticancer Res 41:4343–4351
Caglayan B, Kilic E, Dalay A, Altunay S, Tuzcu M, Erten F, Orhan C, Gunal MY, Yulug B, Juturu V (2019) Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol Biol Rep 46:241–250
Chen N-G, Chen K-T, Lu C-C, Lan Y-H, Lai C-H, Chung Y-T, Yang J-S, Lin Y-C (2010) Allyl isothiocyanate triggers G2/M phase arrest and apoptosis in human brain malignant glioma GBM 8401 cells through a mitochondria-dependent pathway. Oncol Rep 24:449–455
Ling X, Westover D, Cao F, Cao S, He X, Kim H-R, Zhang Y, Chan DC, Li F (2015) Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo. Am J Cancer Res 5:2516
Wang Q, Bao Y (2021) Nanodelivery of natural isothiocyanates as a cancer therapeutic. Free Radical Biol Med 167:125–140
Navarro SL, Li F, Lampe JW (2011) Mechanisms of action of isothiocyanates in cancer chemoprevention: an update. Food Funct 2:579–587
Tarar A, Alyami EM, Peng C-A (2022) Eradication of myrosinase-tethered cancer cells by allyl isothiocyanate derived from enzymatic hydrolysis of sinigrin. Pharmaceutics 14:144
Baspinar Y, Elmaci I, Ozpinar A, Altinoz MA (2020) Long non-coding RNA MALAT1 as a key target in pathogenesis of glioblastoma: Janus faces or Achilles’ heal? Gene 739:144518
Sundaram MK, Preetha R, Haque S, Akhter N, Khan S, Ahmed S, Hussain A (2021) Dietary isothiocyanates inhibit cancer progression by modulation of epigenome. Sem Cancer Biol 83:353–376
Bhattacharya A, Li Y, Wade KL, Paonessa JD, Fahey JW, Zhang Y (2010) Allyl isothiocyanate-rich mustard seed powder inhibits bladder cancer growth and muscle invasion. Carcinogenesis 31:2105–2110
Bhattacharya A, Tang L, Li Y, Geng F, Paonessa JD, Chen SC, Wong MK, Zhang Y (2010) Inhibition of bladder cancer development by allyl isothiocyanate. Carcinogenesis 31:281–286
Savio ALV, da Silva GN, de Camargo EA, Salvadori DMF (2014) Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil). Mutation Res/Fundamental Mol Mech Mutagen 762:40–46
Sávio ALV, da Silva GN, Salvadori DMF (2015) Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil). Mutation Res/Fundamental Mol Mech Mutagen 771:29–35
Chang WJ, Chen BH, Inbaraj BS, Chien JT (2019) Preparation of allyl isothiocyanate nanoparticles, their anti-inflammatory activity towards RAW 264.7 macrophage cells and anti-proliferative effect on HT1376 bladder cancer cells. J Sci Food Agric 99:3106–3116
Jiang Z, Liu X, Chang K, Liu X, Xiong J (2016) Allyl isothiocyanate inhibits the proliferation of renal carcinoma cell line GRC-1 by inducing an imbalance between Bcl2 and Bax. Med Sci Monit 22:4283
Rutz J, Maxeiner S, Grein T, Sonnenburg M, Khadir SE, Makhatelashvili N, Mann J, Xie H, Cinatl J, Thomas A (2022) Allyl-, butyl-and phenylethyl-isothiocyanate modulate Akt–mTOR and cyclin–CDK signaling in gemcitabine-and cisplatin-resistant bladder cancer cell lines. Int J Mol Sci 23:10996
Tseng E, Ramsay EAS, Morris ME (2004) Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines. Exp Biol Med 229:835–842
Singletary K, MacDonald C (2000) Inhibition of benzo [a] pyrene-and 1, 6-dinitropyrene-DNA adduct formation in human mammary epithelial cells bydibenzoylmethane and sulforaphane. Cancer Lett 155:47–54
Kumar A, D’Souza SS, Tickoo S, Salimath BP, Singh H (2009) Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Integr Cancer Ther 8:75–87
Bodo J, Chovancova J, Hunakova L, Sedlak J (2005) Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate. Neoplasma 52:510
Wang X, Govind S, Sajankila SP, Mi L, Roy R, Chung FL (2011) Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res 55:1572–1581
Kim M, Cho HJ, Kwon GT, Kang YH, Kwon SH, Her S, Park T, Kim Y, Kee Y, Park JHY (2015) Benzyl isothiocyanate suppresses high-fat diet-stimulated mammary tumor progression via the alteration of tumor microenvironments in obesity-resistant BALB/c mice. Mol Carcinog 54:72–82
Kim EJ, Hong JE, Eom SJ, Lee J-Y, Park JHY (2011) Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat 130:61–71
Bao C, Kim MC, Chen J, Song J, Ko HW, Lee HJ (2016) Sulforaphene interferes with human breast cancer cell migration and invasion through inhibition of hedgehog signaling. J Agric Food Chem 64:5515–5524
Zhang Z, Atwell LL, Farris PE, Ho E, Shannon J (2016) Associations between cruciferous vegetable intake and selected biomarkers among women scheduled for breast biopsies. Public Health Nutr 19:1288–1295
Rajakumar T, Pugalendhi P, Thilagavathi S (2018) Protective effect of allyl isothiocyanate on glycoprotein components in 7, 12-dimethylbenz (a) anthracene induced mammary carcinoma in rats. Indian J Clin Biochem 33:171–177
Rajakumar T, Pugalendhi P, Thilagavathi S, Ananthakrishnan D, Gunasekaran K (2018) Allyl isothiocyanate, a potent chemopreventive agent targets AhR/Nrf2 signaling pathway in chemically induced mammary carcinogenesis. Mol Cell Biochem 437:1–12
Jiang Z, Dong B, Chen B, Wang J, Xu L, Zhang S, Song H (2013) Multifunctional Au@ mSiO2/rhodamine B isothiocyanate nanocomposites: cell imaging, photocontrolled drug release, and photothermal therapy for cancer cells. Small 9:604–612
Herz C, Hertrampf A, Zimmermann S, Stetter N, Wagner M, Kleinhans C, Erlacher M, Schüler J, Platz S, Rohn S (2014) The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC. J Cell Mol Med 18:2393–2403
Zhang Q-c, Pan Z-h, Liu B-n, Meng Z-w, Wu X, Q-h Z, Xu K (2017) Benzyl isothiocyanate induces protective autophagy in human lung cancer cells through an endoplasmic reticulum stress-mediated mechanism. Acta Pharmacol Sin 38:539–550
Liu P, Behray M, Wang Q, Wang W, Zhou Z, Chao Y, Bao Y (2018) Anti-cancer activities of allyl isothiocyanate and its conjugated silicon quantum dots. Sci Rep 8:1–11
Rakariyatham K, Yang X, Gao Z, Song M, Han Y, Chen X, Xiao H (2019) Synergistic chemopreventive effect of allyl isothiocyanate and sulforaphane on non-small cell lung carcinoma cells. Food Funct 10:893–902
Ahmed AG, Hussein UK, Ahmed AE, Kim KM, Mahmoud HM, Hammouda O, Jang KY, Bishayee A (2020) Mustard seed (Brassica nigra) extract exhibits antiproliferative effect against human lung cancer cells through differential regulation of apoptosis, cell cycle, migration, and invasion. Molecules 25:2069
Mitsiogianni M, Mantso T, Trafalis DT, Vasantha Rupasinghe H, Zoumpourlis V, Franco R, Botaitis S, Pappa A, Panayiotidis MI (2020) Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma. Eur J Nutr 59:557–569
Lu K-W, Lu T-J, Chueh F-S, Lai K-C, Hsia T-C, Peng S-F, Cheng C-C, Chou Y-C, Hsu F-T (2022) Allyl isothiocyanate (AITC) induces apoptotic cell death in vitro and exhibits anti-tumor activity in a human glioblastoma GBM8401/luc2 model. Int J Mol Sci 23:10411
Ko JA, Jeon JY, Park HJ (2012) Preparation and characterization of allyl isothiocyanate microcapsules by spray drying. J Food Biochem 36:255–261
Kumar G, Tuli HS, Mittal S, Shandilya JK, Tiwari A, Sandhu SS (2015) Isothiocyanates: a class of bioactive metabolites with chemopreventive potential. Tumor Biology 36:4005–4016
Liu TT, Yang TS (2010) Stability and antimicrobial activity of allyl isothiocyanate during long-term storage in an oil-in-water emulsion. J Food Sci 75:C445–C451
Zhang Q-F, Jiang Z-T, Li R (2007) Complexation of allyl isothiocyanate with β-cyclodextrin and its derivatives and molecular microcapsule of allyl isothiocyanate in β-cyclodextrin. Eur Food Res Technol 225:407–413
Zhang Z-Q, Pan C-H, Chung D (2011) Tannic acid cross-linked gelatin–gum arabic coacervate microspheres for sustained release of allyl isothiocyanate: characterization and in vitro release study. Food Res Int 44:1000–1007
Pandey A, Dhas N, Deshmukh P, Caro C, Patil P, García-Martín ML, Padya B, Nikam A, Mehta T, Mutalik S (2020) Heterogeneous surface architectured metal-organic frameworks for cancer therapy, imaging, and biosensing: a state-of-the-art review. Coord Chem Rev 409:213212
Lashkari E, Wang H, Liu L, Li J, Yam K (2017) Innovative application of metal-organic frameworks for encapsulation and controlled release of allyl isothiocyanate. Food Chem 221:926–935
Encinas-Basurto D, Ibarra J, Juarez J, Burboa MG, Barbosa S, Taboada P, Troncoso-Rojas R, Valdez MA (2017) Poly (lactic-co-glycolic acid) nanoparticles for sustained release of allyl isothiocyanate: Characterization, in vitro release and biological activity. J Microencapsul 34:231–242
Zhang Z, Garzotto M, Davis EW, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE (2020) Sulforaphane bioavailability and chemopreventive activity in men presenting for biopsy of the prostate gland: a randomized controlled trial. Nutr Cancer 72:74–87
Gupta P, Kim B, Kim SH, Srivastava SK (2014) Molecular targets of isothiocyanates in cancer: recent advances. Mol Nutr Food Res 58:1685–1707
Lewerenz HJ, Bleyl D, Plass R (1992) Subacute oral toxicity study of benzyl isothiocyanate in rats. Food Nahrung 36:190–198
Imaizumi K, Sato S, Sakakibara Y, Mori S, Ohkuma M, Kawashima Y, Ban T, Sasaki H, Tachiyashiki K (2010) Allyl isothiocyanate-induced changes in the distribution of white blood cells in rats. J Toxicol Sci 35:583–589
Kołodziejski D, Piekarska A, Hanschen FS, Pilipczuk T, Tietz F, Kusznierewicz B, Bartoszek A (2019) Relationship between conversion rate of glucosinolates to isothiocyanates/indoles and genotoxicity of individual parts of Brassica vegetables. Eur Food Res Technol 245:383–400
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
PBP wrote the main manuscript text with figures and JKP reviewed and finalize the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
I, the undersigned, give my consent for the publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Patil, P.B., Patel, J.K. Chemopreventive aspects, investigational anticancer applications and current perspectives on allyl isothiocyanate (AITC): a review. Mol Cell Biochem 478, 2763–2777 (2023). https://doi.org/10.1007/s11010-023-04697-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04697-0